Vertex Pharmaceuticals Incorporated Announces Webcast of its Presentation at the Susquehanna Financial Group’s Second Annual SIGnificant Options in Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today announced that the Company will participate in an HCV panel, entitled: "HCV: Protease Inhibitors and Beyond" at Susquehanna Financial Group's Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5, 2008 from 8:15 a.m. to 9:15 a.m. EST. An archive of the presentation will be webcast by Susquehanna immediately following conclusion of the HCV panel.